Free Trial

Equifax (EFX) Stock Forecast & Price Target

Equifax logo
$258.94 -4.95 (-1.88%)
(As of 11/26/2024 ET)

Equifax - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
15

Based on 19 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 4 have given a hold rating, and 15 have given a buy rating for EFX.

Consensus Price Target

$306.74
18.46% Upside
According to the 19 analysts' twelve-month price targets for Equifax, the average price target is $306.74. The highest price target for EFX is $380.00, while the lowest price target for EFX is $267.00. The average price target represents a forecasted upside of 18.46% from the current price of $258.94.
Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

Sign Up

EFX Analyst Ratings Over Time

TypeCurrent Forecast
11/28/23 to 11/27/24
1 Month Ago
10/29/23 to 10/28/24
3 Months Ago
8/30/23 to 8/29/24
1 Year Ago
11/28/22 to 11/28/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
16 Buy rating(s)
13 Buy rating(s)
8 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$306.74$310.47$292.00$216.00
Forecasted Upside18.46% Upside14.98% Upside-3.89% Downside1.39% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Equifax Stock vs. The Competition

TypeEquifaxBusiness Services CompaniesS&P 500
Consensus Rating Score
2.79
2.68
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside18.46% Upside321.90% Upside6.73% Upside
News Sentiment Rating
Positive News

See Recent EFX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/20/2024Stifel Nicolaus
4 of 5 stars
 Lower TargetBuy ➝ Buy$305.00 ➝ $284.00+16.43%
11/19/2024JPMorgan Chase & Co.
3 of 5 stars
 Lower TargetOverweight ➝ Overweight$304.00 ➝ $283.00+16.93%
11/19/2024Oppenheimer
3 of 5 stars
 Lower TargetOutperform ➝ Outperform$315.00 ➝ $286.00+16.60%
10/28/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$350.00 ➝ $350.00+29.68%
10/18/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Haas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
10/18/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$290.00 ➝ $333.00+18.01%
10/1/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Mcveigh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$360.00+22.51%
9/19/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Grobler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$310.00+4.18%
9/13/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$300.00 ➝ $380.00+24.12%
9/12/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$250.00 ➝ $271.00-9.05%
8/20/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$277.00 ➝ $307.00+4.23%
7/24/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$263.00 ➝ $304.00+15.32%
7/18/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$255.00 ➝ $286.00+10.34%
7/9/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Wurtzel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$275.00+13.97%
2/13/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$210.00 ➝ $310.00+21.21%
2/9/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$270.00 ➝ $285.00+14.38%
1/11/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$272.00+11.10%
12/18/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$200.00 ➝ $315.00+28.78%
12/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$218.00 ➝ $267.00+19.05%
11/17/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform
7/21/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$235.00 ➝ $250.00+15.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:29 AM ET.


Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, November 26, 2024. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Equifax Inc.:

  • Equifax Inc. recently reported earnings per share (EPS) of $1.85, exceeding analysts' expectations of $1.84, indicating strong financial performance and effective management.
  • The company has shown a revenue increase of 9.3% compared to the same quarter last year, reflecting growth in its business operations and demand for its services.
  • Equifax Inc. has a solid dividend yield of 0.63%, providing investors with a steady income stream, which is attractive for those seeking regular returns.
  • The stock price is currently around $280.57, which is above its 200-day moving average of $267.82, suggesting a positive trend and potential for further appreciation.
  • With a return on equity of 18.56%, Equifax Inc. demonstrates effective use of shareholder equity to generate profits, which is a positive indicator for investors.

Equifax
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Equifax Inc. for these reasons:

  • The stock has experienced significant insider selling, with the CEO selling over 58,000 shares, which may indicate a lack of confidence in the company's future performance.
  • Equifax Inc.'s dividend payout ratio is 34.67%, which, while manageable, suggests that a significant portion of earnings is being distributed rather than reinvested in growth opportunities.
  • The stock price has fluctuated between a 1-year low of $208.25 and a high of $309.63, indicating volatility that could pose risks for investors looking for stability.
  • With a net margin of 10.07%, there may be concerns about profitability compared to industry standards, which could affect long-term growth potential.
  • Equifax Inc. operates in a competitive market for data and analytics, which may pressure margins and growth as new entrants and technologies emerge.

EFX Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $306.74, with a high forecast of $380.00 and a low forecast of $267.00.

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last year. There are currently 4 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 18.46% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 1 upgrade by analysts.

Analysts like Equifax more than other "business services" companies. The consensus rating score for Equifax is 2.79 while the average consensus rating score for "business services" companies is 2.68. Learn more on how EFX compares to other companies.


This page (NYSE:EFX) was last updated on 11/27/2024 by MarketBeat.com Staff
From Our Partners